Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: Role of short-form leptin receptors and osteopontin

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 287, Issue 5 50-5, 2004, Pages

  Sahai, Atul ^a   Malladi, Padmini ^a   Pan, Xiaomin ^a   Paul, Rachelle ^a   Melin Aldana, Hector ^a   Green, Richard M ^a   Wittington, Peter F ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Diabetes; Fibrosis; Insulin resistance; Obesity; Osteopontin

Indexed keywords

ALANINE AMINOTRANSFERASE; CHOLINE; COLLAGEN TYPE 1; LEPTIN RECEPTOR; MESSENGER RNA; METHIONINE; OSTEOPONTIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL DIET; CONTROLLED STUDY; FEMALE; HEPATITIS; HISTOPATHOLOGY; LEAN BODY WEIGHT; LIVER CELL CULTURE; LIVER FIBROSIS; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; TRICHOME;

ANIMALS; CELL LINE; CHOLINE DEFICIENCY; DEFICIENCY DISEASES; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; FATTY LIVER; FEMALE; LIVER CIRRHOSIS; METHIONINE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; OSTEOPONTIN; RECEPTORS, CELL SURFACE; SIALOGLYCOPROTEINS;

EID: 7044241291     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00199.2004     Document Type: Article

References (59)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 346: 1221-1231, 2002.
2. Berman JS, Serlin D, Li X, Whitley G, Hayes J, Rishikof DC, Ricupero DA, Liaw L, Goetschkes M, and O'Reagan AW. Altered bleomycin-induced lung fibrosis in osteopontin-deficient mice. Am J Physiol Lung Cell Mol Physiol 286: L1311-L1318, 2004.
3. Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 21: 3-16, 2001.
4. Chalasani N, Crabb DW, Cummings OW, Kwo PY, Asghar A, Pandya PK, and Considine RV. Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis? Am J Gastroenterol 98: 2771-2776, 2003.
5. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, More KJ, Breitbart RE, Duyk GM, Tepper RI, and Morgenstern JP. Evidence that diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84: 491-495, 1996.
6. Chiba S, Okamoto H, Kon S, Kimura C, Murakami M, Inobe M, Matsui Y, Sugawara T, Shimizu T, Uede T, and Kitabatake A. Development of atherosclerosis in osteopontin transgenic mice. Heart Vessels 16: 111-117, 2002.
7. Chitturi S, Farrell G, Frost L, Krikrtos A, Lin R, Lidlle C, Samarasinghe D, and George J. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity. Hepatology 36: 403-409, 2002.
8. Cohen B, Novick D, and Rubinstein M. Modulation of insulin activities by leptin. Science 274: 1185-1188, 1996.
9. Collins AR, Schnee J, Wang W, Kim S, Fishbein MC, Bruemmer D, Law RE, Nicholas S, Ross RS, and Hsueh WA. Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart. J Am Coll Cardiol 43: 1698-1705, 2004.
10. Denhardt DT, Giachelli CM, and Rittling SR. Role of osteopontin in cellular signaling and toxicant injury. Annu Rev Pharmacol Toxicol 41: 723-749, 2001.
11. Emilia IP, Farrell GC, Robertson G, Hall P, Kirsch R, and Leclercq I. Central role of PPARα-dependent hepatic lipid turnover in dietary steatohepatitis in mice. Hepatology 38: 123-132, 2003.
12. Fischer JW, Tschope C, Reinecke A, Giachelli CM, and Unger T. Upregulation of osteopontin expression in renal cortex of streptozotocin-induced diabetic rats is mediated by bradykinin. Diabetes 47: 1512-1518, 1998.
13. George J, Pera N, Phung N, Leclercq I, Hou JY, and Farrell G. Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis. J Hepatol 39: 756-764, 2003.
14. Giachelli CM, Pichler R, Lombardi D, Denhardt DT, Alpers CE, Schwartz SM, and Johnson RJ. Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int 45: 515-524, 1994.
15. Gotoh M, Sakamoto M, Kenetaka K, Chuuma M, and Hirohashi S. Overexpression of osteopontin in hepatocellular carcinoma. Pathol Int 52: 19-24, 2002.
16. Han DC, Isono M, Chen S, Casaretto A, Hong SW, Wolf G, and Ziyadeh FN. Leptin stimulates type I collagen production in db/db mesangial cells: glucose uptake and TGF-β type II receptor expression. Kidney Int 59: 1315-1323, 2001.
17. Honda H, Ikejima K, Hirose M, Yoshikawa M, Lang T, Enomoto N, Kitamura T, Yoshiyuki T, and Sato N. Leptin is required for fibrogenic response induced by thioacetamide in the murine liver. Hepatology 36: 12-21, 2002.
18. Hosoi T, Okuma Y, and Nomura Y. Leptin regulates interleukin-1β expression in the brain via the STAT3-independent mechanisms. Brain Res 949: 139-146, 2002.
19. Ikejima K, Takei Y, Honda H, Hirose M, Yoshikawa M, Zhang AJ, Lang T, Fukuda T, Yamashina S, Kitamura T, and Sato N. Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodelling of extracellular matrix in the rat. Gastroenterology 122: 1399-1410, 2002.
20. Isoda K, Nishikawa K, Kamezawa Y, Yoshida M, Kusuhara M, Moroi M, Tada N, and Ohsuzu F. Osteopontin plays an important role in the development of medial thickening and neointimal formation. Circ Res 91: 77-82, 2002.
21. Jansson M, Panoutsakopoulou V, Baker J, Klein L, and Cantor H. Cutting edge: attenuated experimental autoimmune encephalomyelitis in eta-1/osteopontin-deficient mice. J Immunol 168: 2096-2099, 2002.
22. Kawashima R, Mochida S, Matsui A, YouLuTu ZY, Ishikawa K, Toshima K, Yamanobe F, Inao M, Ikeda H, Ohno A, Nagoshi S, Uede T, and Fujiwara K. Expression of osteopontin in Kupffer cells and hepatic macrophages and stellate cells in rat liver after carbon tetrachloride intoxication: a possible factor for macrophage migration into hepatic necrotic areas. Biochem Biophys Res Commun 256: 527-531, 1999.
23. Kirsch R, Clarkson V, Shepard EG, Marais DA, Jaffer MA, Woodburne VE, Kirsch RE, and Hall PM. Rodent nutritional model of non-alcoholic steatohepatitis: species, strain, and sex difference studies. J Gastroenterol Hepatol 18: 1272-1282, 2003.
24. Koniaris LG, Zimmers-Koniaris T, Hsiao EC, Chavin K, Sitzmann JV, and Farber JM. Cytokine-responsive gene-2/IFN-inducible protein-10 expression in multiple models of liver injury and bile duct injury suggests a role in tissue regeneration. J Immunol 167: 399-406, 2001.
25. Koteish A and Diehl AM. Animal models of steatosis. Semin Liver Dis 21: 89-104, 2001.
26. Leclercq IA, Farrell GC, Field J, Bell DR, Gonzalez FJ, and Robertson GR. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 105: 1067-1075, 2000.
27. Leclercq IA, Farrell GC, Schriemer R, and Robertson GR. Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J Hepatol 37: 206-213, 2002.
28. Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, and Friedman JM. Abnormal splicing of the leptin receptor in diabetic mice. Nature 379: 632-635, 1996.
29. Liaw L, Lombardi DM, Almeida MM, Schwartz SM, deBlois D, and Giachelli CM. Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening after endothelial denudation. Arterioscler Thromb Vasc Biol 17: 188-193, 1997.
30. Lin YH, Huang CJ, Chao JR, Chen ST, Lee SF, Yen JJ, and Yang-Yen HF. Coupling of osteopontin and its cell surface receptor CD44 to the cell survival response elicited by interleukin-3 or granulocyte-macrophage colony-stimulating factor. Mol Cell Biol 20: 2734-2742, 2000.
31. Lu SC, Alvarez L, Huang ZZ, Chen L, An W, Corrales FJ, Avila MA, Kanel G, and Mato JM. Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. Proc Natl Acad Sci USA 98: 5560-5565, 2001.
32. Madiehe AM, Herbert S, Mitchell TD, and Harris RBS. Strain-dependent stimulation of growth in leptin-treated obese db/db mice. Endocrinology 143: 3875-3883, 2002.
33. Malyankar UM, Scatena M, Suchland KL, Yun TJ, Clark EA, and Giachelli CM. Osteoprotegerin is an αvβ3-induced, NF-κB-dependent survival factor for endothelial cells. J Biol Chem 275: 20959-20962, 2000.
34. Martinez-Chanter ML, Corrales FJ, Martinez-Cruz LA, Garcia-Trevijano ER, Huang ZZ, Chen L, Kanel G, Avila MA, Mato JM, and Lu SC. Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A. FASEB J 16: 1292-1294, 2002.
35. Matsui Y, Jia N, Okamoto H, Kon S, Onozuka H, Akino M, Liu L, Morimoto J, Rittling SR, Denhardt D, Kitabatake A, and Uede T. Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy. Hypertension 43: 1195-1201, 2004.
36. Mazzali M, Jefferson JA, Ni Z, Vaziri ND, and Johnson RJ. Microvascular and tubulointerstitial injury associated with chronic hypoxia-induced hypertension. Kidney Int 63: 2088-2093, 2003.
37. Mazzali M, Kipari T, Ophascharoensuk V, Wesson JA, Johnson R, and Hughes J. Osteopontin-A molecule for all seasons. QJM 95: 3-13, 2002.
38. Nambi P, Gellai M, Wu HL, and Prabhakar U. Upregulation of osteopontin in ischemia-induced renal failure in rats: a role for ET-1? Biochem Biophys Res Commun 241: 212-214, 1997.
39. Ophascharoensuk V, Giachelli CM, Gordon K, Hughes J, Pichler R, Brown P, Liaw L, Schmidt R, Shankland SJ, Alpers CE, Couser WG, and Johnson RJ. Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int 56: 571-580, 1999.
40. O'Regan A and Berman JS. Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation. Int J Exp Pathol 81: 373-390, 2000.
41. Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N, Cassader M, David E, Cavall Perin P, and Rizzetto M. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 35: 367-372, 2002.
42. Persy VP, Verhulst A, Ysebaert DK, De Greef KE, and De Broe ME. Reduced postischemic macrophage infiltration and interstitial fibrosis in osteopontin knockout mice. Kidney Int 63: 543-553, 2003.
43. Pichler R, Giachelli CM, Lombardi D, Pippin J, Gordon K, Alpers CE, Schwartz SM, and Johnson RJ. Tubulointerstitial disease in glomerulonephritis. Potential role of osteopontin (uropontin). Am J Pathol 144: 915-926, 1994.
44. Potter JP, Rennie-Tankesley L, and Mezey E. Influence of leptin in the development of hepatic fibrosis produced in mice by Schistosoma mansoni infection and by chronic carbon tetrachloride administration. J Hepatol 38: 281-288, 2003.
45. Reid AE. Nonalcoholic steatohepatitis. Gastroenterology 121: 710-723, 2001.
46. Sahai A, Malladi P, Melin-Aldana H, Green RM, and Whitington PF. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. Am J Physiol Gastrointest Liver Physiol 287: G264-G273, 2004.
47. Santamaria E, Avila MA, Latasa MU, Rubio A, Martin-Duce A, Lu SC, Mato JM, and Corrales FJ. Functional proteomics of nonalcoholic steatohepatitis: mitochondrial proteins as targets of S-adenosylmethionine. Proc Natl Acad Sci USA 100: 3065-3070, 2003.
48. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, and Clore JN. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120: 1183-1192, 2001.
49. Saxena NK, Ikeda K, Rockey DC, Friedman SL, and Anania FA. Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice. Hepatology 35: 762-771, 2002.
50. Sharma K, McCue P, and Dunn SR. Diabetic kidney disease in the db/db mice. Am J Physiol Renal Physiol 284: F1138-F1144, 2003.
51. Sodhi CP, Phadke SA, Batlle D, and Sahai A. Hypoxia and high glucose cause exaggerated mesangial cell growth and collagen synthesis: role of osteopontin. Am J Physiol Renal Physiol 280: F667-F674, 2001.
52. Sodhi CP, Phadke SA, Batlle D, and Sahai A. Hypoxia stimulates osteopontin expression and proliferation of cultured vascular smooth muscle cells: potentiation by high glucose. Diabetes 50: 1482-1490, 2001.
53. Tang M, Potter JJ, and Mezey E. Leptin enhances the effect of transforming growth factor β in increasing type I collagen formation. Biochem Biophys Res Commun 197: 906-911, 2002.
54. Towler DA, Bidder M, Latifi T, Coleman T, and Semenkovich CF. Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice. J Biol Chem 273: 30427-30434, 1998.
55. Uygum A, Kadayifci A, Yesilova Z, Erdil A, Yaman H, Saka M, Deveci S, Bagci S, Gulsen M, Karaeren N, and Dagalp K. Serum leptin levels in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 95: 3584-3589, 2000.
56. Whitington PF, Malladi P, Aldana HM, Mack CL, and Sahai A. Upregulation of a Th1 inflammatory cytokine osteopontin in patients with biliary atresia: differential localization at diagnosis and at transplant (Abstract). Hepatology 38: 525A, 2003.
57. Ye QH, Qin LQ, Forgues M, He P, Kim JW, Peng AC, Simon R, Li Y, Robles AI, Chen Y, Ma ZC, Wu ZQ, Ye SL, Liu YK, Tang ZY, and Wang XW. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med 9: 416-423, 2003.
58. Yumoto K, Ishijima M, Rittling SR, Tsuji K, Tsuchiya Y, Kon S, Nifuji A, Uede T, Denhardt DT, and Noda M. Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice. Proc Natl Acad Sci USA 99: 4556-4561, 2002.
59. Zhao AZ, Shinohara MM, Huang D, Shimizu M, Eldar-Finkelman H, Krebs EG, Beavo JA, and Bornfeldt KE. Leptin induces insulin-like signaling that antagonizes cAMP elevation by glucagon in hepatocytes. J Biol Chem 275: 11348-11354, 2000.